VEGFA and asthma: A placebo-controlled intervention study exploring angiogenic modulation upon ICS treatment in patients with asthma revealed a reduction in microvascular angiogenic remodeling in asthmatic airways in terms of a decrease in vessel numbers, VEGF staining, and number of sprouted vessels in airway biopsy specimens [100].